KWALITY PHARMACEUTICALS
Back to Cashflow Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-14 Cr | ₹-17 Cr | ₹0.99 Cr | ₹5.66 Cr | ₹0.77 Cr |
What is the latest Cash Flow from Financing Activities ratio of KWALITY PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-17 Cr |
| Mar2023 | ₹0.99 Cr |
| Mar2022 | ₹5.66 Cr |
| Mar2021 | ₹0.77 Cr |
How is Cash Flow from Financing Activities of KWALITY PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-17 Cr | Negative | |
| Mar2023 | ₹0.99 Cr | -82.43 | |
| Mar2022 | ₹5.66 Cr | 637.55 | |
| Mar2021 | ₹0.77 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,647.1 Cr | 2.4% | -0.7% | 103.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 2.4% |
-0.7% |
103.3% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses